Deutsche Bank Downgrades Abbott Labs (ABT) to Hold to Reflect 'new ABT'
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $105.91 -1.56%
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Join SI Premium – FREE
Deutsche Bank downgraded Abbott Labs (NYSE: ABT) from Buy to Hold with a price target of $33.00 (from $70.00) following real-way trading of newly spun AbbVie (NYSE: ABBV)
The firm comments, "With this note, we are establishing our formal estimates and price target for "new ABT". From a fundamental perspective, we believe new Abbott is an attractive company as it is well-diversified from a product, geographic, and reimbursement risk perspective and has the potential for above peer growth. However, we believe the current share price captures this positive fundamental outlook and our revised price target for "new ABT" is $33 (old was $70). Given the limited upside, we now rate "new ABT" Hold ("old ABT" was a Buy)."
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $33.27 yesterday.
The firm comments, "With this note, we are establishing our formal estimates and price target for "new ABT". From a fundamental perspective, we believe new Abbott is an attractive company as it is well-diversified from a product, geographic, and reimbursement risk perspective and has the potential for above peer growth. However, we believe the current share price captures this positive fundamental outlook and our revised price target for "new ABT" is $33 (old was $70). Given the limited upside, we now rate "new ABT" Hold ("old ABT" was a Buy)."
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $33.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Labs (ABT) PT Lowered to $140 at Barclays
- Nine Entertainment Co Holdings Ltd. (NEC:AU) PT Lowered to AUD1.63 at JPMorgan
- Piper Sandler Downgrades Independent Bank Group (IBTX) to Underweight, 'Expectations of Slower NII Recovery'
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
